NCT03017326 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT03017326
Title	Paediatric Hepatic International Tumour Trial (PHITT)
Acronym	PHITT
Recruitment	Active, not recruiting
Gender	both
Phase	Phase III
Variant Requirements	No
Sponsors	University of Birmingham
Indications	hepatocellular carcinoma hepatoblastoma
Therapies	Cisplatin Carboplatin + Etoposide Gemcitabine + Oxaliplatin + Sorafenib Cisplatin + Doxorubicin + Sorafenib Cisplatin + Doxorubicin + Gemcitabine + Oxaliplatin + Sorafenib Carboplatin + Doxorubicin Irinotecan + Vincristine Sulfate Cisplatin + Doxorubicin + Fluorouracil + Vincristine Sulfate Cisplatin + Doxorubicin Carboplatin + Cisplatin + Doxorubicin
Age Groups:	adult \| child
Covered Countries	POL \| NOR \| NLD \| ISR \| IRL \| GBR \| FRA \| FIN \| ESP \| DEU \| CZE \| CHE \| BEL \| AUT

No variant requirements are available.